Chief Medical Officer of Novocure Ltd (NASDAQ:NVCR), Benaim Ely, sells 2,484 shares worth $389,268
According to Novocure Ltd's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 22 06:39 PM, company Chief Medical Officer, Benaim Ely disclosed selling 2,484 shares at a cost of $156.71. At the time of this transaction (Dec 21), this trade was worth $389,268 in total. As of Dec 21, Benaim Ely now owns 29,356 shares in total worth about $5,019,876.0.
For the last few recent trades made by Novocure Ltd (NASDAQ:NVCR) Chief Medical Officer, Benaim Ely, we have the following information:
- SEC Form 4 filing: Aug 03: Sold 660 shares at the rate of $76.06 per share. Total worth of this trade was $50,200. Total number of shares owned as of Aug 03 were 29,356
- SEC Form 4 filing: Jul 31: Sold 341 shares at the rate of $76.39 per share. Total worth of this trade was $26,048. Total number of shares owned as of Jul 31 were 30,016
- SEC Form 4 filing: May 12: Sold 2,595 shares at the rate of $64.78 per share. Total worth of this trade was $168,104. Total number of shares owned as of May 12 were 12,616
Posted by
George Daniels
on Wednesday December 23 2020, 8:50 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
